Tracked deals
23
23 tracked deals across 2018-2026.
New York, New York, United States
WindRose Health Investors makes private equity investments in businesses that operate within the services sectors of healthcare. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. It manages approximately $7 billion of capital and is currently making new investments out of its seventh fund.
Tracked deals
23
23 tracked deals across 2018-2026.
Recent pace
4
4 tracked deals announced in the last 12 months.
Deal mix
Recapitalization
12 recapitalization · 6 growth capital · 3 addon
Last 8 years
Supporting Data
Showing the 12 most recent of 23 tracked deals for WindRose Health Investors.
Veristat announced it has entered into a definitive agreement to acquire Certara’s Regulatory and Medical Writing business. The deal is expected to close in Q2 2026 and will add 200+ (approximately 220) medical writing and regulatory experts to expand Veristat’s regulatory writing, submission strategy, and advisory capabilities across the drug development lifecycle.
WindRose Health Investors led a transaction merging Clariness and SubjectWell into a single global patient recruitment platform that will operate under the Clariness name. The combined company brings broader geographic reach, technology and a large patient database to support clinical trials across 60+ countries and accelerate enrollment and retention for sponsors, CROs and sites.
WindRose Health Investors has completed a growth investment in Avalon Healthcare Solutions, a Tampa-based diagnostic intelligence and lab benefits management platform. Existing investor Francisco Partners also made an additional investment to support Avalon’s continued product development and scaling for health plan clients.
WindRose Health Investors has made a strategic growth investment in Stellus Rx, a Plano, Texas–based technology-enabled, value-based pharmacy care management platform. The undisclosed transaction will fund Stellus Rx’s expansion of clinical and operational capabilities and the scaling of its platform to serve additional patient populations nationwide.
Court Square Capital Partners and WindRose Health Investors announced a jointly controlled recapitalization of Soleo Health, a Frisco, Texas-based provider of specialty pharmacy and infusion services. The investment will provide capital to scale Soleo's national footprint (26 pharmacies, 30+ infusion suites) and support growth across all 50 states while partnering with the company's founders and management team.
WindRose Health Investors completed a strategic investment to form CIVIE, an AI-powered radiology platform built from Collaborative Imaging's technology. WindRose partnered with Collaborative Imaging's management team to acquire Ci's technology platform; the investment will support product development, sales and operations scale-up, and accelerated growth across radiology practices and hospital systems.
WindRose Health Investors completed a majority growth investment in SubjectWell, the patient-access marketplace that connects motivated patients to clinical trials and treatments. Terms were not disclosed; SubjectWell's management will remain in place and as active shareholders while WindRose provides growth capital to accelerate product development, machine learning and marketplace expansion.
WindRose Health Investors has completed the acquisition of CardioOne, a physician-enablement company serving independent cardiologists, and partnered with CardioOne's executive team to provide up to $100 million of additional capital to support growth. CardioOne's existing management will remain in place and the investment will fund expansion and enhancement of its technology platform and service offerings as the company prepares for value-based care.
WindRose Health Investors completed a growth equity investment in Third Wave Recovery Systems (TWRx) to support the company's expansion in pharmaceutical rebate administration for hospitals, long-term care facilities, and specialty providers. In conjunction with the investment, TWRx acquired SRX, LLC — a rebate management specialist for skilled nursing and long-term care — and appointed a new executive team to lead the combined business.
WindRose Health Investors, a New York-based healthcare private equity firm, has completed a strategic recapitalization investment in BPD, a Boca Raton-based provider of data-driven marketing services for hospitals and health systems. The founders and management team will continue to lead and remain significant shareholders as WindRose supports BPD's expansion of service offerings and accelerated growth.
WindRose Health Investors completed a recapitalization of RevHealth, a Morristown, New Jersey-based omnichannel healthcare communications agency. The investment will provide capital to support RevHealth's growth and expansion of services; founders Bruce Epstein, Bruce Medd, and Brian Wheeler will continue to lead the company and remain significant shareholders.
WindRose Health Investors completed the acquisition of Ganse Apothecary and merged it with Terrapin Pharmacy, an existing WindRose portfolio company, to create a behavioral health-focused pharmacy platform in the Mid-Atlantic. The combined business expands footprint and capabilities across Pennsylvania and surrounding states, serving approximately 7,500 patients across four states; terms were not disclosed.
Turn tracked acquisition activity into an outreach-ready buyer list.